The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.21

Today's change+0.75 +1.77%
Updated June 30 12:47 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.21

Today's change+0.75 +1.77%
Updated June 30 12:47 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC Hits New 20-day High

GlaxoSmithKline PLC is up sharply today, rallying (U.S.)$0.75 or 1.77% to (U.S.)$43.21 and setting a new 20-day high. Over the last five days, shares have gained 1.53% and 7.09% year to date. Shares have outperformed the S&P 500 by 2.45% during the last year.

Key company metrics

  • Open(U.S.) $42.52
  • Previous close(U.S.) $42.46
  • High(U.S.) $43.31
  • Low(U.S.) $42.45
  • Bid / Ask(U.S.) $43.21 / (U.S.) $43.22
  • YTD % change+7.09%
  • Volume2,588,221
  • Average volume (10-day)5,110,878
  • Average volume (1-month)3,741,644
  • Average volume (3-month)3,478,433
  • 52-week range(U.S.) $37.24 to (U.S.) $45.49
  • Beta0.80
  • Trailing P/E129.19×
  • P/E 1 year forward18.39×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.34
  • Dividend yield5.41%
  • Trailing EPS(U.S.) $0.33
Updated June 30 12:47 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue6,2296,2866,1275,888
Total other revenue--------
Total revenue6,2296,2866,1275,888
Gross profit4,1594,0824,0613,993
Total cost of revenue2,0702,2042,0661,895
Total operating expense5,5066,5395,1045,552
Selling / general / administrative2,0762,1221,9142,141
Research & development775846730731
Depreciation / amortization101099
Interest expense (income), net operating--------
Unusual expense (income)651910282838
Other operating expenses, total-76447103-62
Operating income723-2531,023336
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax560-416867152
Income after tax352-428647115
Income tax, total2081222037
Net income282-354538149
Total adjustments to net income--------
Net income before extra. items282-354538149
Minority interest-7074-10934
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items282-354538149
Inc. avail. to common incl. extra. items282-354538149
Diluted net income282-354538149
Dilution adjustment000--
Diluted weighted average shares4,8904,8374,8774,874
Diluted EPS excluding extraordinary itemsvalue per share0.06-0.070.110.03
Dividends per sharevalue per share0.190.230.190.19
Diluted normalized EPSvalue per share0.140.050.150.16